The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

Paxil in 2005, and Zoloft in 2006. Prozac, Luvox, and Wellbutrin have already lost patent protection. However, the extent to which a strategy relying on the use of less costly generic options will ...

Viatris' generic of Symbicort (budesonide and formoterol fumarate dihydrate) – developed by Viatris in collaboration with 3M spin-off company Kindeva Drug Delivery and called Breyna – has been ...

But a generic version of this popular medication, sildenafil, is now widely available from several drug manufacturers at a fraction of the cost. Read on to find out more about this cheaper Viagra ...

Any Australian who has filled a prescription at the chemist will have been asked if they want a branded product or the generic version. And with consumers looking to cut costs wherever they can ...

The drug, called Cobenfy and developed by US pharma giant Bristol Myers Squibb, works differently from existing treatments, targeting the so-called cholinergic receptors, not the dopamine receptors.

Could Google’s hottest recipe search spell health issues? Maybe. Pumpkin seeds, while a nutritional powerhouse, do come with a few considerations to keep i… ...

The FDA recently declined to approve MDMA-assisted therapy for PTSD, but experts said there are many other treatments on the ...

Sept. 26 (UPI) --The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday. The drug, generically called Cobenfy, is the first oral ...

The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...

Drug Administration. Cobenfy (xanomeline/trospium chloride) could bring patients what they've long hoped for: A means of easing the hallucinations and "voices" that disrupt their lives without the ...

Israeli drugmaker Teva Pharmaceuticals (NYSE:TEVA) announced Tuesday the market launch of the first and only U.S. generic for Sandostatin LAR, an antidiarrheal medication marketed by Swiss ...